Last reviewed: December 5, 2019
- A combination of paracervical block, nonsteroidal anti-inflammatory drugs (NSAIDs) and narcotic analgesics, with or without anxiolytics, is recommended.
- Intravenous sedation, where available, should be offered.
- The increased risks of general anesthesia must be weighed against the benefits.
Strength of recommendation: Strong
Quality of evidence: Very Low
Pain during dilatation and evacuation
There is a lack of published evidence regarding the level of pain women experience during D&E, but experts generally agree that abortion procedures become more painful as pregnancy advances. At later gestations, D&E requires more preoperative and operative cervical dilation, longer procedure times and deeper uterine manipulation.
Methods of pain management
Specific studies of pain control during D&E are lacking, and an optimal regimen for pain management has not been established. Studies focus instead on safety of pain management strategies during D&E; and rather than optimizing pain control, most international consensus statements focus on the minimum amount of anesthesia at which a D&E can be performed to ensure access at lower-level facilities (Royal College of Obstetricians and Gynaecologists, 2015; World Health Organization, 2014).
In studies reporting on D&E programs, pain management usually consists of intravenous sedation with a combination of narcotics and anxiolytics, and a paracervical block (Altman, Stubblefield, Schlam, Loberfeld, & Osathanondh, 1985; Castleman, Oanh, Hyman, Thuy, & Blumenthal, 2006; Jacot et al., 1993). Ipas recommends a combination of paracervical block, NSAIDs and narcotic analgesics, with or without anxiolytics (Edelman & Kapp, 2017). Where available, paracervical block with intravenous sedation should be offered.
See “Pain Management: Paracervical block.”
No studies assess the effectiveness of oral, intramuscular or intravenous pain medications during D&E. However, studies of vacuum aspiration have found that pre-procedure administration of oral or intramuscular NSAIDs decreases women’s pain during and after the procedure (Braaten, Hurwitz, Fortin & Goldberg, 2013; Renner, Jensen, Nichols, & Edelman, 2010; Romero, Turok, & Gilliam, 2008; Suprapto & Reed, 1984; Wiebe & Rawling, 1995).
No studies assess the effectiveness of intravenous sedation for pain control during D&E. However, studies of vacuum aspiration have found that intravenous sedation using a combination of narcotics and anxiolytics is an effective means of pain control and improves satisfaction with the abortion procedure (Allen, Fitzmaurice, Lifford, Lasic, & Goldberg, 2009; Allen, Kumar, Fitzmaurice, Lifford, & Goldberg, 2006; Wells, 1992; Wong, Ng, Ngai, & Ho, 2002). Studies that have assessed safety of intravenous sedation with fentanyl and midazolam in combination with paracervical block during D&E have found rates of major procedure-related complications of less than 1% (Racek, Chen, & Creinin, 2010), and no additional anesthesia-related adverse events (Gokhale, Lappen, Waters, & Perriera, 2016; Wilson, Chen, & Creinin, 2009; Wiebe, Byczko, Kaczorowski, & McLane, 2013). Intravenous deep sedation with propofol and without intubation is safe and has few complications in the outpatient setting, and no patients experience pulmonary aspiration (Aksel et al., 2018; Dean, Jacobs, Goldstein, Gervitz & Paul, 2011; Gokhale et al., 2016; Mancuso et al., 2017).
Providing intravenous sedation increases the expense, complexity and potential risks of an abortion procedure; and it requires a trained provider with equipment for patient monitoring. The increased monitoring necessary to deliver intravenous sedation safely requires facility investments in personnel, training and equipment
Although effective for pain control, general anesthesia increases the expense, complexity and potential risks associated with abortion and is not recommended for routine procedures (Atrash, Cheek, & Hogue, 1988; Bartlett et al., 2004; MacKay, Schulz, & Grimes, 1985; WHO, 2014).
Non-pharmacologic pain management
Medications and paracervical block should be supplemented with supportive techniques to decrease pain and anxiety. Helpful approaches may include educating the patient about what to expect during the procedure; conducting the procedure in a clean and private setting with supportive staff; providing verbal support; using gentle and efficient technique; and applying a heating pad or hot water bottle to the lower abdomen in the recovery room (Akin et al., 2001).
Akin, M. D., Weingard, K. W., Hengehold, D. A., Goodale, M. B., Hinkle, R. T., & Smith, R. P. (2001). Continuous low-level topical heat in the treatment of dysmenorrhea. Obstetrics & Gynecology, 97, 343-349.
Aksel, S., Lang, L., Steinauer, J. E., Drey, E. A., Lederle, L., Sokoloff, A., & Carlisle, A. S. (2018). Safety of Deep Sedation Without Intubation for Second-Trimester Dilation and Evacuation. Obstetrics & Gynecology, 132(1), 171-178.
Allen, R.H., Fitzmaurice, G., Lifford, K. L., Lasic, M., & Goldberg, A. (2009). Oral compared with intravenous sedation for first-trimester surgical abortion: A randomized controlled trial. Obstetrics & Gynecology, 113(2Pt1), 276-283.
Allen, R. H., Kumar, D., Fitzmaurice, G., Lifford, K. L., & Goldberg, A. B. (2006). Pain management of first-trimester surgical abortion: Effects of selection of local anesthesia with and without lorazepam or intravenous sedation. Contraception, 74(5), 407-413.
Altman, A. M., Stubblefield, P. G., Schlam, J. F., Loberfeld, R., & Osathanondh, R. (1985). Midtrimester abortion with laminaria and vacuum evacuation on a teaching service. The Journal of Reproductive Medicine, 30(8), 601-606.
Atrash, H., Cheek, T., & Hogue, C. (1988). Legal abortion mortality and general anesthesia. American Journal of Obstetrics & Gynecology, 158(2), 420.
Bartlett, L. A., Berg, C. J., Shulman, H. B., Zane, S. B., Green, C. A., Whitehead, S., & Atrash, H. K. (2004). Risk factors for legal induced abortion-related mortality in the United States. Obstetrics & Gynecology, 103, 729-739.
Braaten, K.P., Hurwitz, S., Fortin, J., & Goldberg, A.B. (2014). Intramuscular ketorolac versus oral ibuprofen for pain relief in first-trimester surgical abortion: A randomized clinical trial. Contraception, 89(2), 116-121.
Castleman, L. D., Oanh, K. T. H., Hyman, A. G., Thuy, L. T., & Blumenthal, P. D. (2006). Introduction of the dilation and evacuation procedure for second-trimester abortion in Vietnam using manual vacuum aspiration and buccal misoprostol. Contraception, 74, 272-276.
Dean, G., Jacobs, A. R., Goldstein, R. C., Gevirtz, C. M., & Paul, M. E. (2011). The safety of deep sedation without intubation for abortion in the outpatient setting. Journal of Clinical Anesthesia, 23437-442.
Edelman, A., & Kapp, N. (2017). Dilatation and evacuation (D&E) reference guide: Induced abortion and postabortion care at or after 13 weeks gestation. Chapel Hill, NC: Ipas.
Gokhale, P., Lappen, J. R., Waters, J. H., & Perriera, L. K. (2016). Intravenous Sedation Without Intubation and the Risk of Anesthesia Complications for Obese and Non-Obese Women Undergoing Surgical Abortion: A Retrospective Cohort Study. Anesthesia and Analgesia, 122(6), 1957-1962.
Jacot, F. R. M., Poulin, C., Bilodeau, A. P., Morin, M., Moreau, S., Gendron, F., & Mercier, D. (1993). A five-year experience with second-trimester induced abortions: No increase in complication rate as compared to the first trimester. American Journal of Obstetrics & Gynecology, 168(2), 633-637.
MacKay, H. T., Schulz, K. F., & Grimes, D. A. (1985). Safety of local versus general anesthesia for second-trimester dilatation and evacuation abortion. Obstetrics & Gynecology, 66, 661-665.
Mancuso, A. C., Lee, K., Zhang, R., Hoover, E. A., Stockdale, C., & Hardy-Fairbanks, A. J. (2017). Deep sedation without intubation during second trimester surgical termination in an inpatient hospital setting. Contraception, 95, 288-291.
Racek, C. M., Chen, B. A., & Creinin, M. D. (2010). Complication rates and utility of intravenous access for surgical abortion procedures from 12 to 18 weeks of gestation. Contraception, 82, 286-290.
Renner, R.M., Jensen, J.T., Nichols, M.D., & Edelman, A.B. (2010). Pain control in first-trimester surgical abortion: A systematic review of randomized controlled trials. Contraception, 81, 372-388.
Romero, I., Turok, D., & Gilliam, M. (2008). A randomized trial of tramadol versus ibuprofen as an adjunct to pain control during vacuum aspiration abortion. Contraception, 77(1), 56-59.
Royal College of Obstetricians and Gynaecologists. (2015). Best Practice Paper No. 2: Best practice in comprehensive abortion care. London: Royal College of Obstetricians and Gynaecologists.
Siddiqui, K. M., & Chohan, U. (2007). Tramadol versus nalbuphine in total intravenous anaesthesia for dilatation and evacuation. Journal of the Pakistani Medical Association, 57(2), 67-70.
Suprapto, K., & Reed, S. (1984). Naproxen sodium for pain relief in first-trimester abortion. American Journal of Obstetrics & Gynecology, 150(8), 1000-1001.
Wells, N. (1992). Reducing distress during abortion: A test of sensory information. Journal of Advanced Nursing, 17, 1050-1056.
Wiebe, E. R., Byczko, B., Kaczorowski, J., & McLane, A. L. (2013). Can we safely avoid fasting before abortions with low-dose procedural sedation? A retrospective cohort chart review of anesthesia-related complications in 47,748 abortions. Contraception, 87, 51-54.
Wiebe, E. R., & Rawling, M. (1995). Pain control in abortion. International Journal of Gynecology & Obstetrics, 50(1), 41-46.
Wilson, L. C., Chen, B. A., & Creinin, M. D. (2009). Low-dose fentanyl and midazolam in outpatient surgical abortion up to 18 weeks of gestation. Contraception, 79, 122-128.
Wong, C. Y., Ng, E. H., Ngai, S. W., & Ho, P. C. (2002). A randomized, double blind, placebo-controlled study to investigate the use of conscious sedation in conjunction with paracervical block for reducing pain in termination of first trimester pregnancy by suction evacuation. Human Reproduction, 17(5), 1222-1225.
World Health Organization. (2014). Clinical handbook for safe abortion care. Geneva: World Health Organization.